Medicament composition for preventing relapse and for treating gastric ulcer
A composition and gastric ulcer technology, applied in the field of medicine, can solve the problems of slow effect and ordinary effect, and achieve the effect of short treatment period, strong antibacterial effect and strong adsorption function
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
preparation example Construction
[0036] The preparation method of chitosan oligosaccharides is: adding dilute lye to the raw material shrimp shells and crab shells to separate the protein and insoluble matter; solution, 110°C, 1h, deacetylated, filtered, etc., treated by enzymatic hydrolysis, dried, and crushed to a fineness of 100 meshes.
[0037]The preparation method of seaweed gel is as follows: take sea plants such as carrageenan (Chondruscrispus; C.ocellatus; Eucheuma cottonii; E.spinosum; Gigartina acicularis spp.) belonging to red algae (Rhondophyceae), extract with hot water, precipitate with alcohols, and It is obtained by drying and pulverizing to a fineness of 100 mesh.
[0038] The preparation method of dietary fiber is as follows: take readily available edible seaweed as raw material, wash and dry it, and then pulverize it. Under the conditions of pH 4-5 and temperature 48-50°C, use protease with an activity unit of 2000U / g for 1 hour. The body was treated by adding 10 times the amount of 0.1mo...
Embodiment 1
[0041] The active ingredient of the pharmaceutical composition of the present embodiment is made from the raw material of following parts by weight:
[0042] Chitooligosaccharide 85 parts
[0043] 10 parts of alginate
[0044] Dietary fiber 5 servings.
[0045] The production method of making the above-mentioned components into capsules is as follows: (1) drying the raw materials respectively and pulverizing them to a fineness above 80 mesh; (2) after fully mixing the above-mentioned powder components according to the proportion, using gamma ray irradiation, Sterilization and disinfection are carried out. The actual absorbed dose of the product is 5.0KGY. Capsules are filled, bottled and packaged according to the capsule filling process.
Embodiment 2
[0047] The active ingredient of the pharmaceutical composition of the present embodiment is made from the raw material of following parts by weight:
[0048] Chitooligosaccharide 80 parts
[0049] 10 parts of alginate
[0050] Dietary fiber 10 servings.
[0051] The production method of making the above-mentioned components into a powder is as follows: (1) drying the raw materials respectively, and pulverizing them to a fineness above 80 meshes; (2) after fully mixing the above-mentioned powder components according to the proportion, using gamma ray irradiation, Sterilization and disinfection are carried out, and the actual absorbed dose of the product is 5.0KGY, and the powder and packaging are prepared according to the powder procedure.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com